InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: noretreat post# 825

Thursday, 06/15/2017 8:21:17 AM

Thursday, June 15, 2017 8:21:17 AM

Post# of 3881
So as promised by company - 2 out of 3 milestones of Q2 checkmarked

Now - crohn's DSMB meeting and interim results remaining

------
RHB-104 - Crohn's disease - DSMB meeting for interim safety and efficacy (this is more like mid-year Q2)

RHB-105 - H pylori - confirmatory P3 study start - Checked

Bekinda - topline results for P3 - checked

-----
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News